Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Outlines strategic priorities for sustaining global vaccine-preventable disease surveillance; leaves open.
Laboratory networks were established to provide accurate and timely laboratory confirmation of infections, an essential component of disease surveillance systems. The World Health Organization (WHO) coordinates global laboratory surveillance of vaccine-preventable diseases (VPDs), including polio, measles and rubella, yellow fever, Japanese encephalitis, rotavirus, and invasive bacterial diseases. In addition to providing high-quality laboratory surveillance data to help guide disease control, elimination, and eradication programs, these global networks provide capacity-building and an infrastructure for public health laboratories. There are major challenges with sustaining and expanding the global laboratory surveillance capacity: limited resources and the need for expansion to meet programmatic goals. Here, we describe the WHO-coordinated laboratory networks supporting VPD surveillance and present a plan for the further development of these networks.
No takes yet. Share an insight, caveat, or question.
Mulders et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: